SCHEMBL1522548

SCHEMBL1522548

CCOC(=O)c1c(O)c2c(C)cccc2n(Cc2ccccc2)c1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.59
LMNA P02545 3/20 0.55
ALDH1A1 P00352 5/20 0.54
HTT P42858 1/20 0.53
MAPT P10636 2/20 0.51
GAA P10253 2/20 0.51
RECQL P46063 1/20 0.51
PKM P14618 1/20 0.51
TSHR P16473 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.48
L3MBTL1 Q9Y468 2/20 0.47
TDP2 O95551 1/20 0.47
NSD2 O96028 1/20 0.47
PLCG1 P19174 1/20 0.47
PAX8 Q06710 1/20 0.47
FEN1 P39748 2/20 0.47
HPGD P15428 1/20 0.45
CASP1 P29466 1/20 0.45
CASP7 P55210 1/20 0.45
HSD17B10 Q99714 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1522936 0.85 KDM4E (0.81) KDM4ELMNAALDH1A1HTTMAPT
SCHEMBL7598991 0.81 ALDH1A1 (0.68) KDM4ELMNAALDH1A1HTTMAPT
SCHEMBL28036699 0.80 KDM4E (0.66) KDM4ELMNAALDH1A1HTTMAPT
SCHEMBL14848270 0.80 KDM4E (0.66) KDM4ELMNAALDH1A1HTTMAPT
SCHEMBL5113359 0.80 FEN1 (0.56) KDM4ELMNAALDH1A1MAPTGAA
SCHEMBL1522907 0.80 KDM4E (0.57) KDM4ELMNAALDH1A1HTTMAPT
SCHEMBL5331127 0.79 KDM4E (0.58) KDM4ELMNAALDH1A1HTTMAPT
SCHEMBL4754692 0.79 ALDH1A1 (0.65) KDM4ELMNAALDH1A1HTTMAPT
SCHEMBL4158509 0.79 FEN1 (0.67) KDM4EALDH1A1MAPTTSHRFEN1
SCHEMBL15966795 0.78 ALDH1A1 (0.67) KDM4ELMNAALDH1A1HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2361913-A1 Anti-infective agents Abbott Laboratories (US) 2011-08-31 EP disclosed
US-7902203-B2 Anti-infective agents ABBOTT LABORATORIES, INC. (US) 2011-03-08 US disclosed
EP-1560827-B1 ANTI-INFECTIVE AGENTS ABBOTT LAB (US) 2010-12-29 EP disclosed
EP-1560827-A1 ANTI-INFECTIVE AGENTS Abbott Laboratories (US) 2005-08-10 EP disclosed
US-20050075331-A1 Anti-infective agents ABBOTT LABORATORIES 2005-04-07 US disclosed
US-20040167123-A1 Anti-infective agents ABBVIE INC. 2004-08-26 US disclosed
US-20040162285-A1 Anti-infective agents ABBOTT LABORATORIES 2004-08-19 US disclosed
WO-2004041818-A1 ANTI-INFECTIVE AGENTS ABBOTT LABORATORIES (US) 2004-05-21 WO disclosed
US-20040097492-A1 Anti-infective agents ABBOTT LABORATORIES 2004-05-20 US disclosed
US-20040087577-A1 Anti-infective agents ABBOTT LABORATORIES 2004-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097492-A1 Anti-infective agents POLR1C, RPL5, POLB KDM4E 4352/4885LMNA 3232/4885ALDH1A1 1434/4885
US-20040162285-A1 Anti-infective agents POLR1C, RPL5, POLB KDM4E 4352/4885LMNA 3232/4885ALDH1A1 1434/4885
US-20040167123-A1 Anti-infective agents SERPINB1, CYP51A1, ZC3HAV1 KDM4E 4075/4885LMNA 4000/4885ALDH1A1 891/4885
US-20050075331-A1 Anti-infective agents RPL35, POLI, POLRMT KDM4E 3897/4885LMNA 4225/4885ALDH1A1 1592/4885
US-20040087577-A1 Anti-infective agents POLR1C, RPL5, POLB KDM4E 4352/4885LMNA 3232/4885ALDH1A1 1434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.